Corrective use of the 2.5-mm GFX stent for suboptimal angioplasty results in small coronary arteries

✍ Scribed by Eric Eeckhout; Michel Grobéty; Pierre Vogt; Jean-Christophe Stauffer; Hristan Roguelov; Philippe Urban; Jean-Jacques Goy

• Publisher: John Wiley and Sons
• Year: 1999
• Tongue: English
• Weight: 138 KB
• Volume: 48
• Category: Article
• ISSN: 1522-1946
• DOI: 10.1002/(sici)1522-726x(199910)48:2<157::aid-ccd7>3.0.co;2-s

✦ Synopsis

To evaluate the clinical efficacy of endoluminal stenting in the setting of percutaneous intervention for small coronary artery lesions, we reviewed our results on stenting with the 2.5-mm GFX stent (Arterial Vascular Engineering, Santa Rosa, CA) during an 18-month study period. A total of 120 patients with significant coronary artery disease in vessels I2.6 mm were followed up clinically. Procedural success (defined as angiographic residual stenosis F20% without clinical complications) was obtained in 94% of cases. In-hospital complications were death (1%), non-Q-wave myocardial infarction (5%), and urgent repeat percutaneous intervention because of stent thrombosis (3%). During a mean follow-up of 9.8 months (range, 6-23 months), the following complications were noted: myocardial infarction (1%), clinical need for repeat intervention (13%) requiring repeat percutaneous treatment (12%) and surgical revascularization (1%). In conclusion, transcatheter application of a specifically designed stent for coronary artery disease in small vessels seems safe and efficient with a low incidence of adverse events during follow-up.